These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effects of combination therapy with a luteinizing hormone-releasing hormone agonist and chlormadinone acetate on rat prostate weight and plasma testosterone levels. Gotanda K, Shinbo A, Okada M, Nakano Y, Kobayashi H, Sasaki T, Hagiwara M, Akaza H. Prostate Cancer Prostatic Dis; 2003 Apr; 6(1):66-72. PubMed ID: 12664069 [Abstract] [Full Text] [Related]
10. Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancer. Labrie C, Cusan L, Plante M, Lapointe S, Labrie F. J Steroid Biochem; 1987 Oct; 28(4):379-84. PubMed ID: 2444770 [Abstract] [Full Text] [Related]
11. Immunolocalization of androgen receptor in canine prostatic hyperplasia--effect of antiandrogen. Murakoshi M, Ikeda R, Tagawa M, Nakayama T, Honma S, Mieda M. Tokai J Exp Clin Med; 1998 Nov; 23(5):209-12. PubMed ID: 10418722 [Abstract] [Full Text] [Related]
14. Androgen receptor binding and antiandrogenic activity of some 4,5-secoandrostanes and ring B cyclopropanoandrostanes. Stárka L, Hampl R, Kasal A, Kohout L. J Steroid Biochem; 1982 Sep; 17(3):331-4. PubMed ID: 6215537 [Abstract] [Full Text] [Related]